Bing Xiong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bing Xiong has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Huanhuan Liu
Department of Rehabilitation, Zhejiang University School of Medicine Second Affiliated Hospital, 88 Jiefang Road, Hangzhou, Zhejiang, 310009, China
2 shared publications- Ying Jin
Department of Rehabilitation Medicine, The Second Affiliated Hospital, Zhejiang University, Hangzhou, 310052, People’s Republic of China
2 shared publications Bin Wang
Department of Anesthesiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang Province, China (Dr B Wang)
1 shared publicationBowen Pan
Department of Traumatology, Affiliated Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children's Health, Hangzhou 310052, China
1 shared publicationChangzheng Yuan
The Second Affiliated Hospital, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China (Y.-H.H., C.Y.).
1 shared publicationDanlei Gu
The Second Affiliated Hospital of Zhejiang University, China
1 shared publication
Latest Publications
- 1 June 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (6) , 1574-1585
Sarcopenia, Grip Strength, Walking Pace, and New-Onset Stroke Risk: A UK Biobank Study
BACKGROUND: Novel stroke risk factors have received widespread attention. This study examined the association between sarcopenia status, grip strength, and walking pace with incident stroke (any stroke, ischemic stroke, and hemorrhagic stroke) and poststroke mortality. METHODS: This prospective study included 482 699 participants from the UK Biobank, a large-scale, population-based cohort. Sarcopenia status was assessed according to the EWGSOP2 criteria (European Working Group on Sarcopenia in Older People 2). Incident strokes were ascertained based on health records. Stroke risk was assessed using multivariable-adjusted Cox proportional hazards models, whereas poststroke mortality was compared using the Kaplan-Meier analysis with log-rank tests. A 2-sample Mendelian randomization analysis, utilizing genetic instruments from public genome-wide association studies, was conducted to infer causal associations. RESULTS: The cohort (mean age±SD: 56.4±8.1 years; 45.37% were men; n=219 015) had a probable sarcopenia prevalence of 4.7% and a confirmed sarcopenia prevalence of 0.4%. Participants with probable sarcopenia had a higher risk of any stroke (adjusted hazard ratio [aHR], 1.30 [95% CI, 1.21−1.39]), ischemic stroke (aHR, 1.31 [95% CI, 1.22−1.42]), and hemorrhagic stroke (aHR, 1.41 [95% CI, 1.20−1.67]) than those without. Among those who had a stroke, probable or confirmed sarcopenia was associated with increased all-cause mortality. Higher risk of any stroke was associated with lower grip strength (absolute: aHR, 1.07 [95% CI, 1.06−1.09] per 5 kg; relative: aHR, 1.36 [95% CI, 1.28−1.44] per 1 kg/[kg/m 2 ]) and a slow walking pace (aHR, 1.64 [95% CI, 1.54−1.75]; compared with brisk pace). Mendelian randomization analysis demonstrated that a faster walking pace was associated with a lower risk of any stroke (odds ratio, 0.94 [95% CI, 0.90−0.97] per-SD increase) and ischemic stroke (odds ratio, 0.95 [95% CI, 0.91−0.98] per-SD increase). CONCLUSIONS: Sarcopenia status, lower grip strength, and slower walking pace were associated with an increased risk of incident stroke and all-cause poststroke mortality.
- 1 June 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (6) , 1574-1585
Sarcopenia, Grip Strength, Walking Pace, and New-Onset Stroke Risk: A UK Biobank Study
BACKGROUND: Novel stroke risk factors have received widespread attention. This study examined the association between sarcopenia status, grip strength, and walking pace with incident stroke (any stroke, ischemic stroke, and hemorrhagic stroke) and poststroke mortality. METHODS: This prospective study included 482 699 participants from the UK Biobank, a large-scale, population-based cohort. Sarcopenia status was assessed according to the EWGSOP2 criteria (European Working Group on Sarcopenia in Older People 2). Incident strokes were ascertained based on health records. Stroke risk was assessed using multivariable-adjusted Cox proportional hazards models, whereas poststroke mortality was compared using the Kaplan-Meier analysis with log-rank tests. A 2-sample Mendelian randomization analysis, utilizing genetic instruments from public genome-wide association studies, was conducted to infer causal associations. RESULTS: The cohort (mean age±SD: 56.4±8.1 years; 45.37% were men; n=219 015) had a probable sarcopenia prevalence of 4.7% and a confirmed sarcopenia prevalence of 0.4%. Participants with probable sarcopenia had a higher risk of any stroke (adjusted hazard ratio [aHR], 1.30 [95% CI, 1.21−1.39]), ischemic stroke (aHR, 1.31 [95% CI, 1.22−1.42]), and hemorrhagic stroke (aHR, 1.41 [95% CI, 1.20−1.67]) than those without. Among those who had a stroke, probable or confirmed sarcopenia was associated with increased all-cause mortality. Higher risk of any stroke was associated with lower grip strength (absolute: aHR, 1.07 [95% CI, 1.06−1.09] per 5 kg; relative: aHR, 1.36 [95% CI, 1.28−1.44] per 1 kg/[kg/m 2 ]) and a slow walking pace (aHR, 1.64 [95% CI, 1.54−1.75]; compared with brisk pace). Mendelian randomization analysis demonstrated that a faster walking pace was associated with a lower risk of any stroke (odds ratio, 0.94 [95% CI, 0.90−0.97] per-SD increase) and ischemic stroke (odds ratio, 0.95 [95% CI, 0.91−0.98] per-SD increase). CONCLUSIONS: Sarcopenia status, lower grip strength, and slower walking pace were associated with an increased risk of incident stroke and all-cause poststroke mortality.
- Open Access
- 6 January 2026
- Published by Elsevier in Brain Research Bulletin
- Vol. 234, 111718
Alternations of gray matter lateralization and structural covariation in the children with developmental dyslexia and isolated spelling deficit
- 6 January 2026
- Published by Elsevier in Brain Research Bulletin
- Vol. 234, 111718
Open AccessAlternations of gray matter lateralization and structural covariation in the children with developmental dyslexia and isolated spelling deficit
- Open Access
- 20 November 2025
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 53 (11)
Effectiveness and safety of a lower-limb walking assist device for motor function recovery in subacute stroke patients: A prospective, randomized, open, parallel-controlled, noninferiority study
Objective: To evaluate the effectiveness and safety of the MI-R1 lower-limb walking assist device for gait training in subacute stroke patients. Methods: The experimental group received lower-limb function training using the lower-limb training device. In contrast, the control group received lower-limb function training provided by a therapist. After 4 weeks, the patients were evaluated for certain indicators. The primary outcome was the Fugl–Meyer Assessment Lower Extremity score on day 28 (±7 days). The secondary outcomes included the Functional Ambulation Category score, Modified Barthel Index score, safety indicators, and incidence of adverse events. Results: After treatment, the noninferiority statistic between the experimental and control groups was −0.1976 (−1.5051, 1.1099). The lower limit of the 95% confidence interval was greater than the noninferiority margin. There was no significant difference in the Functional Ambulation Category or Modified Barthel Index scores between the experimental and control groups at 0, 14, and 28 days ( p > 0.05). There was no statistically significant difference in vital signs or adverse event rates between the experimental and control groups ( p > 0.05). Conclusions: The MI-R1 lower-limb walking assist device is not inferior to traditional rehabilitation in achieving lower-limb function recovery in subacute stroke patients and is associated with good patient safety. Trial registration: ClincialTrials, Unique identifier: NCT06564480 (retrospectively registered)
- 20 November 2025
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 53 (11)
Open AccessEffectiveness and safety of a lower-limb walking assist device for motor function recovery in subacute stroke patients: A prospective, randomized, open, parallel-controlled, noninferiority study
Objective: To evaluate the effectiveness and safety of the MI-R1 lower-limb walking assist device for gait training in subacute stroke patients. Methods: The experimental group received lower-limb function training using the lower-limb training device. In contrast, the control group received lower-limb function training provided by a therapist. After 4 weeks, the patients were evaluated for certain indicators. The primary outcome was the Fugl–Meyer Assessment Lower Extremity score on day 28 (±7 days). The secondary outcomes included the Functional Ambulation Category score, Modified Barthel Index score, safety indicators, and incidence of adverse events. Results: After treatment, the noninferiority statistic between the experimental and control groups was −0.1976 (−1.5051, 1.1099). The lower limit of the 95% confidence interval was greater than the noninferiority margin. There was no significant difference in the Functional Ambulation Category or Modified Barthel Index scores between the experimental and control groups at 0, 14, and 28 days ( p > 0.05). There was no statistically significant difference in vital signs or adverse event rates between the experimental and control groups ( p > 0.05). Conclusions: The MI-R1 lower-limb walking assist device is not inferior to traditional rehabilitation in achieving lower-limb function recovery in subacute stroke patients and is associated with good patient safety. Trial registration: ClincialTrials, Unique identifier: NCT06564480 (retrospectively registered)
- Open Access
- 9 May 2025
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 25 (1) , 540-551
Relationship between sleep disorders and depression in perimenopausal women in the United States: a cross-sectional survey based on NHANES 2009-2014
Background: Many studies have found that depression and sleep disorders in perimenopausal women often appear as comorbidities, but its relevance has not been further verified. To clarify the relationship between the two can provide guidance for future clinical research.Methodology: A cross-sectional research was carried out among 1400 women aged 45-55 years who participated in the 2009-2014 national health and Nutrition Examination Survey (NHANES). We estimated unadjusted and adjusted logistic regression models to analyze the relationship between sleep disturbances and other related factors with depression.Results: 18.1% of the 1440 participants had depressive symptoms in the past two weeks. 11.2% had sleep disorder. Compared with women without sleep disorder (14.70%), depression was more common in perimenopausal women who had sleep disorder (44.72%), In the logistic regression model, menopausal women with sleep disturbance suffer from depression were four times more than that without sleep disturbance (odds ratio, 3.798; 95%CI, 2.611-5.525); The difference remained significant after adjusted the effects of covariates (adjusted odds ratio, 3.687; 95% CI, 2.533-5.367).Conclusion: Sleep disorders strongly link to depression in menopausal women. Early intervention for sleep issues may reduce depression risk in this group. Keywords: Sleep disorders; depression; perimenopausal women; NHANES.
- 9 May 2025
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 25 (1) , 540-551
Open AccessRelationship between sleep disorders and depression in perimenopausal women in the United States: a cross-sectional survey based on NHANES 2009-2014
Background: Many studies have found that depression and sleep disorders in perimenopausal women often appear as comorbidities, but its relevance has not been further verified. To clarify the relationship between the two can provide guidance for future clinical research.Methodology: A cross-sectional research was carried out among 1400 women aged 45-55 years who participated in the 2009-2014 national health and Nutrition Examination Survey (NHANES). We estimated unadjusted and adjusted logistic regression models to analyze the relationship between sleep disturbances and other related factors with depression.Results: 18.1% of the 1440 participants had depressive symptoms in the past two weeks. 11.2% had sleep disorder. Compared with women without sleep disorder (14.70%), depression was more common in perimenopausal women who had sleep disorder (44.72%), In the logistic regression model, menopausal women with sleep disturbance suffer from depression were four times more than that without sleep disturbance (odds ratio, 3.798; 95%CI, 2.611-5.525); The difference remained significant after adjusted the effects of covariates (adjusted odds ratio, 3.687; 95% CI, 2.533-5.367).Conclusion: Sleep disorders strongly link to depression in menopausal women. Early intervention for sleep issues may reduce depression risk in this group. Keywords: Sleep disorders; depression; perimenopausal women; NHANES.
- Top Cited PapersOpen Access
- 21 January 2025
- Published by Springer Nature in Molecular Cancer
- Vol. 24 (1) , 1-27
Tailoring traditional Chinese medicine in cancer therapy
Cancer remains a formidable global health challenge, necessitating innovative therapeutic approaches to enhance treatment efficacy and reduce adverse effects. The traditional Chinese medicine (TCM), as an embodiment of ancient wisdom, has been validated to regulate the holistic human capacity against both internal and external “evils” in accordance with TCM principles. Therefore, it stands to reason to integrate TCM into current cancer therapy paradigms, such as chemotherapy, immunotherapy, and targeted therapy. This strategy conceptually intends to circumvent the inevitable side effects derived from present treatment, alleviate the discomfort, mollify the detrimental mood and synergize tumoricidal effects of distinct approaches. However, it is still vague whether TCM exert favorable function in cancer treatment. Therefore, it is imperative to retrieve and compile the existing literature on TCM in the realm of cancer, followed by a comprehensive recapitulation and synthesis of its core findings. Recently, with the advancement of contemporary biologic and medical theory and technology, it has become both feasible and imperative to elucidate the molecular signaling mechanisms and cellular biology underlying TCM. Specifically, leveraging TCM pharmaceutic components can not only directly impact tumor biology at the molecular level, but regulate the tumor immune environment through distinct pathways. Additionally, the administration of external TCM treatments such as acupuncture and moxibustion also demonstrates beneficial effects in cancer patients. Through comprehensive analysis, we demonstrated that TCM not only potentially increases the efficacy of conventional cancer treatments, but also significantly mitigates their toxic side effects, thereby prolonging patients’ prognosis and improving their living quality. Furthermore, we have underscored the challenges and prospects associated with the integration of TCM into contemporary oncological practices, placing particular emphasis on the imperative for rigorous clinical trials and molecular investigations to substantiate the efficacy and safety of these combined therapeutic approaches. This synthesis aims to pave the way for a more integrated approach to cancer treatment rooted in both traditional wisdom and cutting-edge science.
- 21 January 2025
- Published by Springer Nature in Molecular Cancer
- Vol. 24 (1) , 1-27
Top Cited PapersOpen AccessTailoring traditional Chinese medicine in cancer therapy
Cancer remains a formidable global health challenge, necessitating innovative therapeutic approaches to enhance treatment efficacy and reduce adverse effects. The traditional Chinese medicine (TCM), as an embodiment of ancient wisdom, has been validated to regulate the holistic human capacity against both internal and external “evils” in accordance with TCM principles. Therefore, it stands to reason to integrate TCM into current cancer therapy paradigms, such as chemotherapy, immunotherapy, and targeted therapy. This strategy conceptually intends to circumvent the inevitable side effects derived from present treatment, alleviate the discomfort, mollify the detrimental mood and synergize tumoricidal effects of distinct approaches. However, it is still vague whether TCM exert favorable function in cancer treatment. Therefore, it is imperative to retrieve and compile the existing literature on TCM in the realm of cancer, followed by a comprehensive recapitulation and synthesis of its core findings. Recently, with the advancement of contemporary biologic and medical theory and technology, it has become both feasible and imperative to elucidate the molecular signaling mechanisms and cellular biology underlying TCM. Specifically, leveraging TCM pharmaceutic components can not only directly impact tumor biology at the molecular level, but regulate the tumor immune environment through distinct pathways. Additionally, the administration of external TCM treatments such as acupuncture and moxibustion also demonstrates beneficial effects in cancer patients. Through comprehensive analysis, we demonstrated that TCM not only potentially increases the efficacy of conventional cancer treatments, but also significantly mitigates their toxic side effects, thereby prolonging patients’ prognosis and improving their living quality. Furthermore, we have underscored the challenges and prospects associated with the integration of TCM into contemporary oncological practices, placing particular emphasis on the imperative for rigorous clinical trials and molecular investigations to substantiate the efficacy and safety of these combined therapeutic approaches. This synthesis aims to pave the way for a more integrated approach to cancer treatment rooted in both traditional wisdom and cutting-edge science.
- 22 December 2023
- Published by Elsevier in Neuroscience Letters
- Vol. 820, 137611
Electroacupuncture prevents the development or establishment of chronic pain via IL-33/ST2 signaling in hyperalgesic priming model rats
- 22 December 2023
- Published by Elsevier in Neuroscience Letters
- Vol. 820, 137611
Electroacupuncture prevents the development or establishment of chronic pain via IL-33/ST2 signaling in hyperalgesic priming model rats
- Open Access
- 1 December 2022
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 5 (2) , 100826
Efficacy of electroacupuncture combined with intravenous patient-controlled analgesia after cesarean delivery: a randomized clinical trial
- 1 December 2022
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
- Vol. 5 (2) , 100826
Open AccessEfficacy of electroacupuncture combined with intravenous patient-controlled analgesia after cesarean delivery: a randomized clinical trial
- Open Access
- 23 February 2021
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 49 (2)
Efficacy and safety of a modified method for blind bedside placement of post-pyloric feeding tube: a prospective preliminary clinical trial
Objective: To compare the efficacy and safety of a new modified method of bedside post-pyloric feeding tube catheterization with the Corpak protocol versus electromagnetic-guided catheterization. Materials and Methods: We conducted a single-center, single-blinded, prospective clinical trial. Sixty-three patients were treated with a non-gravity type gastrointestinal feeding tube using different procedures: modified bedside post-pyloric feeding tube placement (M group), the conventional Corpak protocol (C group), and standard electromagnetic-guided tube placement (EM group). Results: The success rate in the M group, C group, and EM group was 82.9% (34/41), 70.7% (29/41), and 88.2% (15/17), respectively, with significant differences among the groups. The time required to pass the pylorus was significantly shorter in the M group (26.9 minutes) than in the C group (31.9 minutes) and EM group (42.1 minutes). The proportion of pylorus-passing operations completed within 30 minutes was significantly higher in the M group than in the C group and EM group. No severe complications occurred. Conclusion: This modified method of bedside post-pyloric feeding tube catheterization significantly shortened the time required to pass the pylorus with no severe adverse reactions. This method is effective and safe for enteral nutrition catheterization of patients with dysphagia and a high risk of aspiration pneumonia.
- 23 February 2021
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 49 (2)
Open AccessEfficacy and safety of a modified method for blind bedside placement of post-pyloric feeding tube: a prospective preliminary clinical trial
Objective: To compare the efficacy and safety of a new modified method of bedside post-pyloric feeding tube catheterization with the Corpak protocol versus electromagnetic-guided catheterization. Materials and Methods: We conducted a single-center, single-blinded, prospective clinical trial. Sixty-three patients were treated with a non-gravity type gastrointestinal feeding tube using different procedures: modified bedside post-pyloric feeding tube placement (M group), the conventional Corpak protocol (C group), and standard electromagnetic-guided tube placement (EM group). Results: The success rate in the M group, C group, and EM group was 82.9% (34/41), 70.7% (29/41), and 88.2% (15/17), respectively, with significant differences among the groups. The time required to pass the pylorus was significantly shorter in the M group (26.9 minutes) than in the C group (31.9 minutes) and EM group (42.1 minutes). The proportion of pylorus-passing operations completed within 30 minutes was significantly higher in the M group than in the C group and EM group. No severe complications occurred. Conclusion: This modified method of bedside post-pyloric feeding tube catheterization significantly shortened the time required to pass the pylorus with no severe adverse reactions. This method is effective and safe for enteral nutrition catheterization of patients with dysphagia and a high risk of aspiration pneumonia.